Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.38
Nov 20 • 4:00 PM ET Dollar change-0.01 Percentage change(-0.72%)
Aftermarket Close
1.38
Aftermarket • 5:00 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
1.71M
Enterprise Value
2.15M
Income
-9.37M
Sales
0.28M
Book/sh
0.32
Cash/sh
0.64
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
8
IPO
Sep 16, 2022
P/E
-
Forward P/E
-
PEG
-
P/S
6.10
P/B
4.34
P/C
2.16
P/FCF
-
EV/EBITDA
-
EV/Sales
7.67
Quick Ratio
0.59
Current Ratio
0.69
Debt/Eq
4.73
LT Debt/Eq
1.00
Option/Short
No / Yes
EPS (ttm)
-13.61
EPS next Y
-7.55
EPS next Q
-2.91
EPS this Y
23.87%
EPS next Y
33.89%
EPS next 5Y
-
EPS past 3/5Y
-29.12% -1.42%
Sales past 3/5Y
-38.88% 4.43%
EPS Y/Y TTM
23.24%
Sales Y/Y TTM
76.71%
EPS Q/Q
10.69%
Sales Q/Q
331.43%
Insider Own
21.36%
Insider Trans
0.00%
Inst Own
4.06%
Inst Trans
4.52%
ROA
-222.85%
ROE
-372.62%
ROIC
-1780.61%
Gross Margin
-744.57%
Oper. Margin
-3386.02%
Profit Margin
-3380.59%
SMA20
-9.46%
SMA50
-53.88%
SMA200
-85.68%
Trades
Shs Outstand
1.24M
Shs Float
0.97M
52W High
33.60 -95.89%
52W Low
1.31 5.34%
Volatility
8.17% 10.36%
ATR (14)
0.26
RSI (14)
29.58
Beta
4.26
Rel Volume
0.01
Avg Volume
1.02M
Volume
13,975
Perf Week
-6.76%
Perf Month
-32.02%
Perf Quarter
-85.42%
Perf Half Y
-87.82%
Perf YTD
-91.76%
Perf Year
-95.31%
Perf 3Y
-84.87%
Perf 5Y
-
Perf 10Y
-
Prev Close
1.39
Price
1.38
Change %
-0.72%
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices help people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
PresidentMr. Mark White
Chief Medical OfficerDr. David Owens M.D.
Co-Founder and Director of Engineering & DevelopmentMr. John Patrick Claude
Chief Financial OfficerMr. Justin Van Fleet CPA